Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 49,721 | 17,501 | 27,762 | 240,031 | 263,701 |
| Cost of Goods | 9,456 | 3,618 | 3,293 | 111,630 | 140,082 |
| Gross Profit | 40,265 | 13,883 | 24,469 | 128,401 | 123,619 |
| Operating Expenses | 99,711 | 97,255 | 115,414 | 409,726 | 222,239 |
| Operating Income | -58,990 | -82,754 | -90,652 | -280,695 | -98,538 |
| Interest Expense | 3,110 | 3,036 | 4,095 | 18,211 | 20,790 |
| Other Income | 10,388 | 3,256 | -48 | 884 | 664 |
| Pre-tax Income | -51,712 | -82,534 | -94,795 | -298,022 | -118,664 |
| Income Tax | -20 | 315 | -5,782 | -27,121 | -8,983 |
| Net Income Continuous | -51,692 | -82,849 | -89,013 | -270,901 | -109,681 |
| Net Income Discontinuous | N/A | 17,929 | 9,424 | N/A | N/A |
| Net Income | $-51,692 | $-64,920 | $-79,589 | $-270,901 | $-109,681 |
| EPS Basic Total Ops | -0.58 | -0.96 | -1.31 | -5.17 | -2.42 |
| EPS Basic Continuous Ops | -0.58 | -1.23 | -1.47 | -5.17 | -2.42 |
| EPS Basic Discontinuous Ops | N/A | 0.27 | 0.16 | N/A | N/A |
| EPS Diluted Total Ops | -0.58 | -0.96 | -1.31 | -5.17 | -2.42 |
| EPS Diluted Continuous Ops | -0.58 | -1.23 | -1.47 | -5.17 | -2.42 |
| EPS Diluted Discontinuous Ops | N/A | 0.27 | 0.16 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.68 | -1.05 | -0.37 | 0.25 | -0.51 |
| EBITDA(a) | $-42,242 | $-65,093 | $3,826 | $60,067 | $87,256 |